Nabriva Therapeutics (NBRV)
NASDAQ: NBRV
· Real-Time Price · USD
1.42
0.01 (0.71%)
At close: Jul 31, 2023, 10:00 PM
Nabriva Therapeutics Revenue
Nabriva Therapeutics reported an annual revenue of $35.67M, reflecting a 31.06% growth. For the quarter ending March 31, 2023, Nabriva Therapeutics generated $7.59M in revenue.
Revenue (ttm)
35.67M
Revenue Growth
31.06%
Price / Sales Ratio
0.14
Revenue / Employee
914.56K
Employees
39
Market Cap
4.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2022 | 35.67M | +31.06% |
| Dec 31, 2021 | 27.22M | +850.28% |
| Dec 31, 2020 | 2.86M | -63.04% |
| Dec 31, 2019 | 7.75M | +19.20% |
| Dec 31, 2018 | 6.5M | +Infinity% |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | -100.00% |
| Dec 31, 2015 | 84K | +Infinity% |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |